Vanguard Group’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.39M | Sell |
|
|||||
|
2024
Q3 | $4.93M | Hold |
|
|||||
|
2024
Q2 | $3.28M | Sell |
|
|||||
|
2024
Q1 | $25.4M | Buy |
|
|||||
|
2023
Q4 | $29.1M | Buy |
|
|||||
|
2023
Q3 | $20.7M | Buy |
|
|||||
|
2023
Q2 | $27.7M | Buy |
|
|||||
|
2023
Q1 | $15.1M | Buy |
|
|||||
|
2022
Q4 | $7.93M | Buy |
|
|||||
|
2022
Q3 | $11.2M | Buy |
|
|||||
|
2022
Q2 | $8.11M | Sell |
|
|||||
|
2022
Q1 | $15.9M | Buy |
|
|||||
|
2021
Q4 | $20.1M | Sell |
|
|||||
|
2021
Q3 | $19.3M | Sell |
|
|||||
|
2021
Q2 | $31M | Buy |
|
|||||
|
2021
Q1 | $26.4M | Buy |
|
|||||
|
2020
Q4 | $19.3M | Buy |
|
|||||
|
2020
Q3 | $16.3M | Buy |
|
|||||
|
2020
Q2 | $11.9M | Buy |
|
|||||
|
2020
Q1 | $7.51M | Buy |
|
|||||
|
2019
Q4 | $7.57M | Buy |
|
|||||
|
2019
Q3 | $3.52M | Sell |
|
|||||
|
2019
Q2 | $10.7M | Buy |
|
|||||
|
2019
Q1 | $10.3M | Buy |
|
|||||
|
2018
Q4 | $6.34M | Buy |
|
|||||
|
2018
Q3 | $15.6M | Sell |
|
|||||
|
2018
Q2 | $11.1M | Buy |
|
|||||
|
2018
Q1 | $4.97M | Buy |
|
|||||
|
2017
Q4 | $10.4M | Buy |
|
|||||
|
2017
Q3 | $4.9M | Buy |
|
|||||
|
2017
Q2 | $800K | Sell |
|
|||||
|
2017
Q1 | $1.16M | Buy |
|
|||||
|
2016
Q4 | $188K | Sell |
|
|||||
|
2016
Q3 | $665K | Buy |
|
|||||
|
2016
Q2 | $360K | Buy |
|
|||||
|
2016
Q1 | $1.48M | Buy |
|
|||||
|
2015
Q4 | $1.41M | Buy |
|
|||||
|
2015
Q3 | $463K | Buy |
|
|||||
|
2015
Q2 | $379K | Buy |
|